Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis

2021/04/09 by Jawad Bilal, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi +12 · 1 citation
Medicine · #Venous Thromboembolism Diagnosis and Management #Heparin-Induced Thrombocytopenia and Thrombosis #Myeloproliferative Neoplasms: Diagnosis and Treatment

paper · doi:10.1016/j.mayocp.2020.12.035

Citations

• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis
• Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study

Cited by

• Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?